Costes sanitarios de la población con diabetes mellitus tipo 2 en el País Vasco (España)

  1. Roberto Nuño Solinís 1
  2. E. Alonso Morán
  3. José Maria Arteagoitia Axpe 2
  4. Patxi Ezkurra Loyola 3
  5. Juan F. Orueta 3
  6. Sonia Gaztambide Saenz 4
  1. 1 Universidad de Deusto
    info

    Universidad de Deusto

    Bilbao, España

    ROR https://ror.org/00ne6sr39

  2. 2 Eusko Jaurlaritza. Osasun Saila
  3. 3 Osakidetza
  4. 4 Universidad del País Vasco/Euskal Herriko Unibertsitatea
    info

    Universidad del País Vasco/Euskal Herriko Unibertsitatea

    Lejona, España

    ROR https://ror.org/000xsnr85

Montrer des affiliations +
Revue:
Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición

ISSN: 1575-0922

Année de publication: 2016

Volumen: 63

Número: 10

Pages: 543-550

Type: Article

DOI: 10.1016/J.ENDONU.2016.08.003 DIALNET GOOGLE SCHOLAR

D'autres publications dans: Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición

Objectifs de Développement Durable

Résumé

Objective The aim of the study was to estimate the direct costs of healthcare provided to patients with type 2 diabetes mellitus (T2DM) in the Basque Country and to compare them with those of the population with chronic diseases. Material and methods A retrospective, cross-sectional, population-based study. Direct healthcare costs for patients aged over 35 years diagnosed with T2DM in the Basque Country (n = 126,894) were calculated, stratified by age, sex and deprivation index, and compared to the costs for the population diagnosed with a chronic disease other than T2DM (n = 1,347,043). Results The annual average healthcare cost of a person with T2DM was €3,432. Cost gradually increased with age to €4,313 in patients aged 80 to 84 years. Cost in males were €161 higher as compared to costs in females (P < .001). In the most socioeconomically disadvantaged areas, cost per patient was €468 (14.9%) greater than in the most privileged areas (P < .001). Moreover, cost was 68.5% higher (P < .001) for patients with T2DM than for patients with other chronic diseases. Total annual direct costs amounted to €435.5 million, or 12.78% of total public health expenditure in the region. Conclusions Direct mean healthcare costs in the Basque Country for patients with T2DM were higher in males, in the most underprivileged areas, in patients with comorbidities, and in older age groups, and represented €3,432 per person per year.

La source de données: Dialnet